The recent resurgence of meme stock trading in 2025 has highlighted concerning patterns in market behavior, with stocks like OPEN and KSS experiencing dramatic price increases without fundamental justification. While media outlets often portray these events as harmless retail trader antics, they represent deeper structural issues within today’s market
Actelis Networks (NASDAQ: ASNS) continues to demonstrate commercial momentum with today’s announcement of a new order from a member of a large Pan European Telecom Group for its GigaLine backhaul technology, marking another significant milestone in the company’s rapid expansion across multiple geographic and vertical markets. The latest
The passage of significant stablecoin legislation in the Senate through the GENIUS Act, coupled with the House’s upcoming “Crypto Week,” represents a fundamental transformation in financial services. With a decisive 68-30 vote, lawmakers have established comprehensive federal oversight for stablecoins, encompassing crucial aspects like reserve requirements, issuer transparency,
In today’s digital landscape, those who dare to speak truth face unprecedented challenges and consequences. Society has evolved into an environment where inconvenient facts are met not with thoughtful consideration, but with mockery and dismissal. The bearers of uncomfortable truths find themselves targeted and marginalized, while those who maintain
A federal court judge has rejected the Department of Justice’s petition to make public grand jury transcripts connected to Jeffrey Epstein’s mid-2000s criminal investigation. U.S. District Judge Robin Rosenberg issued a 12-page ruling on July 23, explaining that her court lacks the authority under 11th
A major cybersecurity breach has struck the National Nuclear Security Administration (NNSA), with threat actors exploiting a previously unknown vulnerability in Microsoft SharePoint software. The sophisticated cyberattack, which security experts characterize as one of the year’s most significant intrusions into U.S. defense infrastructure, has been attributed by Western
TL;DR: FDA Breakthrough for Revolution Medicine’s Daraxonrasib and Verastem’s Progress Further Highlight the Excitement Surrounding the KRAS-targeting landscape; Silexion Positioned as an Under-the-Radar Player in the Field as it Advances Unique RNAi Approach Silexion Therapeutics (NASDAQ: SLXN) appears to be approaching a pivotal inflection
Tech giant Microsoft revealed on Tuesday that Chinese state-sponsored hacking groups have been actively exploiting vulnerabilities in the company’s SharePoint collaboration software to launch widespread cyber attacks against various organizations. The company identified three distinct Chinese threat actors – Linen Typhoon, Violet Typhoon, and Storm-2603 – who have been
The global landscape is undergoing profound transformation, with nations grappling to find purpose and direction in an increasingly uncertain world. As immediate challenges consume government attention, deeper questions about societal identity and long-term objectives remain largely unexplored. Several key developments are reshaping the international order. The United States, under
A major controversy has erupted over the allocation of $100 million raised during a star-studded FireAid benefit concert intended to help homeless residents of Pacific Palisades following a devastating wildfire. Investigative reporting has revealed that the funds, meant to provide immediate relief to thousands who lost their homes, may
The Biden administration’s ambitious initiative to transition the United States Postal Service fleet to electric vehicles has encountered significant challenges, with recent reports revealing concerning inefficiencies and cost overruns. A New York Post investigation has uncovered that despite a massive $10 billion investment, only 250 electric mail trucks have
Pharmaceutical company Sarepta Therapeutics announced Monday evening that it will temporarily halt all shipments of its Duchenne muscular dystrophy gene therapy Elevidys across the United States, following reports of three patient deaths linked to the treatment. The company’s decision came shortly after Children’s Hospital Los Angeles suspended its
